Stay updated with breaking news from Clinical Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Prof. Munirdeen Ijaiya of the Department of Obstetrics and Gynaecology, University of Ilorin (UNILORIN), says he has invented a surgical procedure for the treatment of Vesico Vaginal Fistula (VVF).
ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero
Adding BXCL701 to Keytruda tended to improve overall survival outcomes for patients with small cell neuroendocrine prostate cancer, according to phase 2 study results.
Treatment with the combination of the investigational oral innate immune activator BXCL701 and pembrolizumab led to a median overall survival of 13.6 months in patients with small cell neuroendocrine carcinoma metastatic castration-resistant prostate cancer.